-
Haemophagocytic lymphohistiocytosis (HLH) secondary to measles in an adult with a loss of post-vaccination humoral immunity following rituximab Lancet Infect Dis (IF 36.4) Pub Date : 2025-06-03
Alp Aslan Notghi, Joseph Delahunty, Rachel S Tattersall, Benjamin StoneMeasles is an important re-emergent infectious disease globally. Vaccine immunity at the population level is key to the prevention of outbreaks, as unvaccinated or immunosuppressed adults are particularly vulnerable to severe infection. With the increasing use of immunomodulatory treatments for autoimmune and malignant conditions, the long-term effects of CD20-expressing cell-depleting therapies on
-
Neuroinvasive Oropouche virus in a patient with HIV from extra-Amazonian Brazil Lancet Infect Dis (IF 36.4) Pub Date : 2025-06-03
Felipe Donateli Gatti, Joana Zorzal Nodari, Thiago de Jesus Sousa, Gabriela Colombo de Mendonça, Eric Arrivabene Tavares, Iara Almeida Pinto, Julia Del Piero Pereira, Joaquim Batista Ferreira Filho, Valéria Pereira Cabral, Suwellen Sardinha Dias de Azevedo, Anna Clara Gregório Có, Jaqueline Pegoretti Goulart, Felipe Gomes Naveca, Edson Delatorre, Rodrigo Ribeiro-RodriguesNo Abstract
-
Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USA Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-06-03
Natalie N. Tarbuck, Sofya K. Garushyants, Dillon S. McBride, Patricia M. Dennis, John Franks, Karlie Woodard, Austin Shamblin, Michael G. Sovic, Derek T. Collins, Kyle Van Why, Richard J. Webby, Martha I. Nelson, Andrew S. BowmanFree-ranging white-tailed deer (WTD) are highly susceptible to the SARS-CoV-2 virus. Through an opportunistic sampling of WTD in northeast Ohio, USA, during January–March 2023, we identified 6 SARS-CoV-2 lineages from 36 sequences using the pangolin lineages tool, including the B.1.1.7 lineage (Alpha variant) and BQ.1.1, BQ.1.1.63, BQ.1.1.67, BQ.1.23, and XBB.1.5.35 lineages (Omicron variant). The
-
Skin microbiota in atopic dermatitis: victim or executioner? Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2025-06-03
Chiara Maria Teresa BoggioFederica VeroneseMarta ArmariElisa ZavattaroElia EspostoPaola SavoiaBarbara Azzimonti1Laboratory of Applied Microbiology, Department of Health Sciences (DiSS), Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), School of Medicine, Università del Piemonte Orientale202516, Novara, Italy2Dermatology Unit, Department of Health Sciences (DiSS), SchoolClinical Microbiology Reviews, Ahead of Print.
-
The choice of viral load endpoint in early phase trials of COVID-19 treatments aiming to reduce 28-day hospitalization and/or death J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-04
Allyson Mateja, Eric Chu, Thomas A Murray, Carolyn T Bramante, Carlee Moser, Naomi Givens, Mazin Abdelghany, Chris Blair, Shuguang Chen, Prince Kumar Lat, Ofir Harari, Nicole L Kallewaard, Lisa Farmer Macpherson, David R Boulware, Clara Suñer, Oriol Mitjà, Stacey J Adam, Victor De Gruttola, Michael D Hughes, Daniel Rubin, Davey M Smith, Gail E PotterBackground Virologic endpoints are used in Phase 2 trials for COVID-19 therapeutics, but they have not been established as surrogates for clinical endpoints. No meta-analysis using individual participant data (IPD) has been undertaken to identify viral load outcomes for which treatment effects are best associated with effects on hospitalization/death. Methods This meta-analysis combined IPD from 23
-
Long-term effects of azithromycin mass administration to reduce childhood mortality on Streptococcus pneumoniae antimicrobial resistance: a population-based, cross-sectional, follow-up carriage survey Lancet Infect Dis (IF 36.4) Pub Date : 2025-06-02
Akuzike Kalizang'oma, Jia Mun Chan, Khumbo Kalua, Farouck Bonomali, Comfort Brown, Jacqueline Msefula, David Chaima, Lyson Samikwa, Harry Meleke, John D Hart, Alison Craik, Chrispin Chaguza, Rory Cave, Jennifer Cornick, Brenda Kwambana-Adams, Stephen D Bentley, Thandie Mwalukomo, Dorothee Van Breevoort, Robin Bailey, Ana Belén Ibarz-Pavón, Robert S HeydermanBackgroundMass drug administration (MDA) programmes with the macrolide antibiotic azithromycin to reduce childhood mortality are expanding in Africa; however, concerns remain about the long-term effects of these programmes on antimicrobial resistance (AMR). We aimed to evaluate the persistence and spread of Streptococcus pneumoniae AMR following a community-randomised MDA trial. MethodsThis population-based
-
Sociodemographic and Occupational Factors Associated With Coronavirus Disease 2019 Vaccine and Influenza Vaccine Uptake Among Healthcare Workers, in Albania, 2022–2023: A Multicenter Study Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-06-03
Anisa Xhaferi, Silvia Bino, Rovena Daja, Adela Vasili, Jonilda Sulo, Nana Mebonia, Earta Ndreu, Miljana Nika, Nadire Jani, Ermiona Dabaj, Nensi Sustarova, Anila Moçi, Dorina Toçi, Albana Fico, Eugena Tomini, Sara Robinson, Pernille Jorgensen, Mark A KatzBackground Healthcare workers (HCWs) are a priority group for coronavirus disease 2019 (COVID-19) and influenza vaccination. We evaluated sociodemographic and occupational factors, attitudes, and knowledge associated with the uptake of primary and booster doses of COVID-19 and seasonal influenza vaccines among HCWs. Methods Between February 2022 and February 2023, we administered a structured questionnaire
-
B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
James J Knox, Ingi Lee, Emily A Blumberg, Aaron M Rosenfeld, Wenzhao Meng, Fang Liu, Charlotte Kearns, Una O’Doherty, Abraham Shaked, Kim M Olthoff, Eline T Luning PrakBackground Solid organ transplant recipients (SOTRs) suffer increased morbidity and mortality due, in part, to chronic immunosuppression. The determination of an individual's immune competence is currently difficult but would improve risk assessment and inform medical decisions. We reasoned that correlating qualitative and quantitative measures of the B-cell compartment with serologic responses to
-
Using Machine Learning Algorithms to Identify Key Predictors of Invasive Mold Infection Surveillance J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
Samantha L Williams, Zainab Salah, Brendan R Jackson, Sebastian Wurster, Jose A Serpa, Carolyn Z Grimes, Robert L Atmar, Tom M Chiller, Dimitrios P Kontoyiannis, Luis Ostrosky-Zeichner, Mitsuru TodaBackground Invasive mold infections (IMI) can lead to severe morbidity and mortality, but routine public health surveillance is lacking. Although extensive evaluation is needed for clinical diagnosis, case classification prediction models may inform surveillance efforts, which are essential to better characterize epidemiologic trends and assess the value of a more inclusive IMI case definition. Methods
-
Differentiating SARS-CoV-2 antibody responses between infection and vaccination: challenges for epidemiological research J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
Sunav N Nayagam, William Coote, Matthew T C Carroll, Zheng Quan Toh, Paul V Licciardi, Michael J Abramson, Karen Walker-Bone, Tyler J LaneSome common COVID-19 vaccines elicit antibody responses that most serological tests are unable to differentiate from an infection response. This presents a challenge for COVID-19 surveillance and epidemiology. In this perspective, we examine the potential scale of this problem.
-
Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-03
Natalie M Deschenes, Jimena Pérez-Vargas, Zoe Zhong, Merrilee Thomas, Calem Kenward, Wesley A Mosimann, Liam J Worrall, Nicholas Waglechner, Angel XinLiu Li, Finlay Maguire, Patryk Aftanas, Jason R Smith, Jared Lim, Robert N Young, Artem Cherkasov, Lubna Farooqi, Adnan Moinuddin, Lina Siddiqi, Imaan Malik, Maxime Lefebvre, Mark Paetzel, Natalie C J Strynadka, François Jean, Allison McGeer, Robert ABackground The main protease (Mpro) is one of the most attractive targets for antiviral drug discovery against SARS-CoV-2. Mutations in Mpro have been linked to resistance against nirmatrelvir-ritonavir (NIR-RIT), an important therapy for SARS-CoV-2 infection. This study aimed to identify low-frequency antiviral resistance mutations in Mpro from NIR-RIT-treated patients and to analyze the enzymatic
-
Increasing Predominance of Norovirus GII.17 over GII.4, United States, 2022–2025 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-06-02
Leslie Barclay, Jan VinjéNorovirus GII.17 outbreaks in the United States increased from <10% during the 2022–23 season to 75% during the 2024–25 season, surpassing the number of GII.4 outbreaks. The norovirus season also started earlier in 2024–25 than in previous seasons. Continued norovirus surveillance is needed to detect and monitor emerging strains.
-
Clinical and microbiological characteristics of meningococcal eye infections: retrospective national surveillance in England, 2010-2022 Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-06-02
Stephen A Clark, Emma Heymer, Helen Campbell, Sonia Ribeiro, Aiswarya Lekshmi, Jay Lucidarme, Xilian Bai, Shamez N Ladhani, Ray BorrowObjectives Neisseria meningitidis is primarily associated with severe systemic infections but can infect the eye and periocular tissues. Most meningococcal eye infections have a mild prognosis, but there is a significant increase in the risk of invasive disease. UK public health guidelines recommend chemoprophylaxis for meningococcal eye infection cases and contacts. This study involved a clinical
-
Impact of puberty on immune responses to Mycobacterium tuberculosis in South African adolescents J. Infect. Dis. (IF 5.0) Pub Date : 2025-06-02
Léanie Kleynhans, Elizna Maasdorp, Candice I Snyders, James A SeddonBackground As individuals progress through adolescence, their risk of tuberculosis (TB) increases and the type of disease that develops changes, with increasing cavitary formation and parenchymal tissue destruction. While it is widely assumed that the changes in risk and disease phenotype are due to puberty exerting an impact on host immune responses to Mycobacterium tuberculosis, this relationship
-
Multicenter Retrospective Study of Spiroplasma ixodetis Infantile Cataract in 8 Countries in Europe. Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-06-01
Luc Van Os,Nathalie Cassoux,Symira Cholidis,Pascal Dureau,Navid Farassat,Fabienne Catherine Fierz,Ebba Ghyczy,Elena-Cristina Nitulescu,Eva Stifter,Marie-José Tassignon,Anne Le Flèche-Matéos,Birgit Lorenz,Spiroplasma ixodetis has been reported to cause the rare combination of cataract and uveitis in infants. Through a retrospective analysis of available literature and additional unpublished cases, we identified 28 eyes from 18 infants from 8 countries in Europe with cataracts and intraocular inflammation. The cataracts were bilateral in 55.6%, unilateral in 44.4%, and progressive in 46.4% of patients
-
The (Re)-emerging And ePidemic Infectious Diseases (RAPID) Stigma Scales: a cross-outbreak scale development and pyschometric validation study Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-30
Amy Paterson, Kondwani K Mughogho, Ashleigh Cheyne, Olive Kabajaasi, Tonmoy Sarkar, Kkunsa Hadson Dimitrios, Harun Tulunay, Frances N Adiukwu, Saad S Alatrany, Ebrahim Aliafsari Mamaghani, Lorena G Barberia, He Bu, Precious Chikura-Dlamini, Jake Dunning, Ernesto R Gregorio, Md Zakiul Hassan, Mohammad B Hossain, Euzebiusz Jamrozik, Sabuj Kanti Mistry, Gerald A Mwima, Amanda RojekReducing stigma during infectious disease outbreaks is crucial for delivering an effective response. However, no validated stigma scales exist for use across outbreaks, and outbreak-specific scales are developed too slowly to guide timely interventions. To enable more real-time monitoring and mitigation of stigma across outbreak contexts, we developed and validated the (Re)-emerging and ePidemic Infectious
-
Evidence of Viremia in Dairy Cows Naturally Infected with Influenza A Virus, California, USA Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-05-30
Jason Lombard, Chloe Stenkamp-Strahm, Brian McCluskey, Blaine MelodyWe confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA. Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies.
-
Human Streptococcus suis Infections, South America, 1995–2024 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-05-30
M’hensa Vincent De Paul Bakpatina-Batako, Kevin Li, Sonia Lacouture, Lucía Cipolla, Ariel Gianecini, Mónica Prieto, Marcelo Gottschalk, Nahuel FittipaldiStreptococcus suis, a swine pathogen that causes zoonotic infections in Europe and Asia, has increasingly been observed in South America. We reviewed all available reports from the continent and identified S. suis cases in Argentina, Brazil, Chile, French Guiana, and Uruguay. We also identified 8 novel infections from Argentina, bringing the total documented human cases in South America to 47. We reclassified
-
Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-31
Jennifer Audsley, Anchalee Avihingsanon, Xin Li, Rosalind Edwards, Kathy Jackson, Nadia Warner, Olivia Maslac, Peter Revill, Hay Mar Su Lwin, Sivaporn Gatechompol, Nagalingeswaran Kumarasamy, Tim Spelman, Iskandar Azwa, Adeeba Kamarulzaman, Sharon R Lewin, Joe SasadeuszBackground An effective therapeutic strategy for HBV cure remains an urgent unmet need. We aimed to define the incidence, kinetics and predictors of hepatitis B surface antigen (HBsAg) loss in people living with HIV and HBV (PLWH-HBV) following HBV-active antiretroviral therapy (ART) in PLWH-HBV in Asia. Method 97 PLWH-HBV commencing HBV-active ART were recruited prospectively in Thailand (n=94) and
-
Secondary Pneumococcal Disease in Veterans with Viral Respiratory Infections Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-31
Lauren A Powers, Arthur K Chan, Bethany A Wattengel, Matthew Davis, Ashley L O’Leary, Jiachen Xu, John C Hu, Kari A MergenhagenBackground Post-viral secondary bacterial infection, such as those caused by Streptococcus pneumoniae, are strongly associated with influenza and respiratory syncytial virus (RSV). However, data evaluating this relationship with coronavirus disease 2019 (COVID-19) is limited. Methods A retrospective analysis was conducted in hospitalized patients in Veterans Affairs (VA) Hospitals across the United
-
Host determinants for the spread of PVL-positive Staphylococcus aureus in Sub-Saharan Africa J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Tobias Grebe, Viktoria Rudolf, Christiane Sidonie Gouleu, Tomiwa Olumide Adesoji, Claujens Chastel Mfoutou Mapanguy, Mary Oladokun, Anke Siegmund, Le Thi Kieu Linh, Silke Niemann, Bettina Löffler, Ayola Akim Adegnika, Francine Ntoumi, Thirumalaisamy P Velavan, Adebayo Osagie Shittu, Frieder SchaumburgThe Panton-Valentine leukocidin (PVL) of Staphylococcus aureus can be associated with severe and recurrent skin and soft tissue infections (SSTI). The prevalence of PVL is particularly high in Sub-Saharan Africa. We assessed in a multi-center cross-sectional study whether host-related factors could explain this high PVL prevalence. We find higher serum anti-PVL-IgG levels in participants from Africa
-
Genome-scale meta-analysis of host responses to Staphylococcus aureus identifies pathways for host-directed therapeutic targeting J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Clark D Russell, Seraphima Goeldner-Thompson, Emilie Smith, Jonathan E Millar, Bo Wang, Nicholas Parkinson, Sara Clohisey Hendry, Maaike Swets, J Ross Fitzgerald, J Kenneth Baillie, David H DockrellBackground Staphylococcus aureus infections are frequently complicated by metastatic foci, recurrence, and death. Antimicrobial resistance and intracellular bacterial persistence limit the effectiveness of conventional antimicrobials. Host-directed therapies could improve outcomes, but the interpretive complexity of pathogen-host interactions impedes identification of critical responses suitable for
-
Longitudinal Analysis of Nasopharyngeal Microbial Risk Markers for Fatal Acute Febrile Illness in a Zambian Birth Cohort J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Aubrey R Odom, Jessica Anderson, Christopher J Gill, Rachel Pieciak, Arshad Ismail, William B MacLeod, W Evan Johnson, Rotem LapidotIntroduction Fatal acute febrile illness (fAFI) is a known predecessor of many infant mortality events in low-resource settings, yet early risk markers for this condition remain poorly understood. Nasopharyngeal (NP) microbiome patterns may influence the severity of these infections. Methods We analyzed longitudinal changes in the NP microbiota of Zambian infants with fAFI onset compared to healthy
-
Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche (DREAM-02) J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-31
Ruohui Zheng, Edward J Fuchs, Sridhar Nimmagadda, Lisa C Rohan, Lin Wang, Lynn N Bertagnolli, Sandra Massih, Brian S Caffo, Craig W HendrixBackground Men who have sex with men are at high risk of HIV acquisition through unprotected receptive anal intercourse (RAI). Behaviorally-congruent HIV PrEP has long been advocated by individuals who find adherence challenging or prefer minimizing systemic drug concentrations. We developed an event-driven, behaviorally-congruent rectal tenofovir (TFV) douche as a PrEP option for RAI and demonstrated
-
COVID-19 mortality in Africa and Asia Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-29
Sandro VentoNo Abstract
-
Correction to Lancet Infect Dis; published online May 19. https://doi.org/10.1016/S1473-3099(25)00341-X Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-29
Có ACG, de Mendonça GC, Gatti FD, et al. Unravelling the pathogenesis of Oropouche virus. Lancet Infect Dis 2025; published online May 19. https://doi.org/10.1016/S1473-3099(25)00341-X—In this Correspondence, Joaquim Batista Ferreira Filho should have been included as an author. This correction has been made to the online version as of May 29, 2025, and will be made to the printed version.
-
COVID-19 mortality in Africa and Asia – Authors' reply Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-29
Philip Bejon, Ambrose Agweyu, Isabella Oyier, Mainga Hamaluba, Dorcas Kamuya, Sam Kinyanjui, Edwine BarasaNo Abstract
-
Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-05-29
Kaitlin Benedict, Alexander Jordan, Jeremy A.W. Gold, Dallas J. Smith, Tom Chiller, Ian Hennessee, Philip M. Polgreen, Susan E. BeekmannWe polled infectious disease specialists about cryptococcal antigen screening for patients initiating HIV antiretroviral therapy. Of 215 respondents, 33% reported typically obtaining screening for patients with CD4 counts <200 cells/mm3 and 63% for counts <100 CD4 cells/mm3. Uncertainty about cryptococcal antigen screening benefits and recommendations suggests opportunities for education and increased
-
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2025-05-29
Jacques G. MainilKeiji NakamuraRie IkedaFlorence CrombéJacob DiderichMarc SaulmontDenis PiérardDamien ThiryTetsuya Hayashi1Veterinary Bacteriology, Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine and Centre for Fundamental and Applied Research for Animals and Health (FARAH), University of Liège (ULiège), Liège, Belgium2Department of Bacteriology, Faculty of Medical SciencesClinical Microbiology Reviews, Ahead of Print.
-
Biologic drug development for treatment and prevention of sexually transmitted infections Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2025-05-29
Davinder S. GillSanjay RamPeter A. Rice1StiRx Inc, Mansfield, Massachusetts, USA2Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School164186https://ror.org/0464eyp60, Worcester, Massachusetts, USAGraeme N. ForrestJonathan ZenilmanClinical Microbiology Reviews, Ahead of Print.
-
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2025-05-28
Tania DayJack D. Sobel1Maternity and Gynaecology, John Hunter Hospital37024https://ror.org/0187t0j49, New Lambton Heights, New South Wales, Australia2University of Newcastle School of Medicine and Public Health64837, Callaghan, New South Wales, Australia3Division of Infectious Diseases, Wayne State University2954https://ror.org/01070mq45, Detroit, Michigan, USAFerry HagenTori FordClinical Microbiology Reviews, Ahead of Print.
-
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-30
Veronique de Jager, Laurynas Mockeliunas, Huifang You, Ulrika S H Simonsson, Tarryn Collings, Caryn M Upton, Johannes A Bezuidenhout, Nikhil Gupte, Susan Dorman, Eric Nuermberger, Gyanu Lamichhane, Andreas H Diacon, Kelly E DooleyBackground In vitro, meropenem is shown to restore the activity of rifampicin in rifampicin-resistant Mycobacterium tuberculosis strains. This phase 2a trial aimed to determine if addition of rifampicin increases the early bactericidal activity (EBA) of meropenem plus amoxicillin/clavulanate in patients with rifampicin-resistant tuberculosis (RR-TB). Methods Individuals with RR-TB were randomized to
-
Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-30
Yanhong Li, Madison E Stellfox, Kirsten M Evans, Emma G Mills, Kevin M Squires, Ava J Dorazio, Ryan K Shields, Daria Van TyneEnterococcus faecalis is an opportunistic pathogen that causes infective endocarditis. Despite in vitro synergy of the recommended combination ampicillin and ceftriaxone (AC), E. faecalis infective endocarditis (EFIE) mortality remains high. We characterized 119 isolates from EFIE patients in our health system from 2018 to 2023 genomically and phenotypically. Three genetic lineages (ST6, ST40, and
-
Interferon-γ therapy in patients with refractory disseminated coccidioidomycosis Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-29
Chen Wang, Brenna A LaBere, Michell M Lozano Chinga, Annalie J Harris, Lindsey B Rosen, Amanda Elias Rivera, Eva Le Run, Keith A Sacco, Wassim Ballan, James V Woodward, Scott A Ostdiek, Matthew W Smith, Victoria L Anderson, Janine R Daub, Cindy L Palmer, Lavenda Chirombo Kluczynski, Andrew J Oler, Magdalena A Walkiewicz, Rajarshi Ghosh, Morgan Similuk, Fariba M Donovan, John Witt, Nicolas Barros, LRefractory disseminated coccidioidomycosis (DCM) is a severe disease with limited treatment options. This report reviews our own and prior published experiences using adjunctive interferon-γ therapy in refractory DCM, showing overall favorable responses in patients without Signal Transducer and Activator of Transcription 1 gain-of-function mutations.
-
Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trial Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-29
Susan E Purchase, Joanna Brigden, James A Seddon, Neil A Martinson, Lee Fairlie, Suzanne Staples, Thomas Wilkinson, Trinh Duong, H Simon Schaaf, Anneke C HesselingBackground Young children have a high risk of developing tuberculosis (TB) disease following infection with Mycobacterium tuberculosis (M.tb) in the absence of preventive treatment. Infection prevalence and risk factors for infection impact delivery of prevention strategies. We aimed to determine the prevalence of infection in child household contacts aged < 5 years exposed to adults with confirmed
-
Differences in Neutrophil Counts Between African and non-African Countries in two International Clinical Trials J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Ruth N Moro, John L Johnson, Neil Martinson, Grace Muzanyi, Chi-Chiu Leung, Kwok-Chiu Chang, Ziyaad Waja, Stefan V GoldbergBackground Differences in absolute neutrophil count (ANC) between African and non-African populations have been reported. Neutropenia has also been reported during rifamycin use. ANC values in current tables that assign severity grades to clinical or laboratory events (The National Cancer Institute Common Terminology Criteria for Adverse Events [CTCAE] and the National Institute of Allergy and Infectious
-
Efficacy of RTS,S/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Nathanial K Copeland, Lucas Otieno, June Doryne Otieno, Solomon Otieno, Salome Chira, Karen Ivinson, Irene Onyango, Ruth Wasuna, Hoseah Akala, Amos Onditi, Peter Sifuna, Ben Andagalu, Roselyne Oyugi, Mary Omondi, Stellah Amoit, Emily Locke, Scott Gregory, Elke S Bergmann-Leitner, Hema Pindolia, Mike Raine, Chris Gast, Laina D Mercer, John J Aponte, Marc Lievens, Christian F Ockenhouse, Cynthia K LeeBackground RTS,S/AS01 vaccine efficacy (VE) was previously shown as lower in African adults than in malaria-naïve US adults, potentially due to concurrent Plasmodium falciparum (Pf) infections. We investigated whether treatment of infection prior to vaccination would lead to improved VE and immunogenicity. Methods A Phase 2b study in Kenyan adults evaluated the efficacy of RTS,S/AS01E in conjunction
-
Impact of Population Immunity and Public Health Measures on the Transmission of Omicron Subvariants BA.2 and BA.5 in Hong Kong J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Can Wang, Hsiang-Yu Yuan, Eric H Y Lau, Benjamin J Cowling, Dennis K M Ip, Tim K TsangBackground The rapid evolution of SARS-CoV-2 and population-level vaccine administration significantly shift the population immunity. In Hong Kong, these shifts, coupled with the emergence of Omicron BA.5 with a strong ability of immune evasion, necessitate a deeper understanding of how population immunity and public health and social measures have shaped the epidemic dynamics across age groups within
-
HIV-Superinfection in Kidney Transplant Recipients with HIV who Received Organs from Donors with HIV J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Gracie M Rozek, Ping Yang, Yolanda Eby, Sarah E Benner, Craig Martens, Feben Habtehyimer, Maggie Chahoud, Diane Brown, Niraj M Desai, Sander Florman, Meenakshi M Rana, Marcus R Pereira, Jonathan Hand, Sapna A Mehta, Joanna Schaenman, Carlos A Q Santos, Saima Aslam, Nahel Elias, Jonah Odim, Megan Morsheimer, Dorry L Segev, Christine M Durand, Aaron A R Tobian, Andrew D ReddTransplantation of kidneys from donors with HIV to recipients with HIV (HIV D+/R+) has been shown to be safe and effective, but there is a unique risk of donor-derived HIV-superinfection (HIV-SI) in these recipients. Recipients from a multicenter observational HIV D+/R+ study were examined for HIV-SI using site-directed next-generation sequencing (Illumina). Eighteen HIV D+/R+ kidney transplant recipients
-
Tracing the Origin of the 2022 Dengue Virus Epidemic in Karachi, Pakistan, through Genome Analyses J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-29
Jeeyou Kim, Minkyu Park, Donghoon Shin, Zohaib Ul Hassan, Ibrar Ahmed, Nazish Badar, Mohammed Saeed Quraishy, Salman Ahmed Khan, Misbah Anwar, Nur A Hasan, Min-gyung Baek, Seil Kim, Hana YiBackground The 2022 dengue outbreak in Karachi, Pakistan, posed a severe threat to the region, yet no study has investigated the origins of the causal strain. Methods This study aimed to trace the origins and transmission route of the dengue virus serotype 1 (DENV-1) strain responsible for the 2022 epidemic through genome sequencing and phylogenetic analyses. We successfully sequenced 135 complete
-
Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-05-27
Gerard C. Kelly, Agus Rachmat, Long Khanh Tran, Chonthida Supaprom, Hip Phireak, Satharath Prom, Heng Sopheab, Nora Cleary, Michael von Fricken, Christina M. Farris, Andrew G. LetiziaDuring 2007–2020, we conducted a cross-sectional prevalence study among patients with acute undifferentiated febrile illness to describe the burden and long-term epidemiology of rickettsioses in Cambodia. Serum samples were collected from 10,243 participants, along with epidemiologic data, information on clinical symptoms, demographic characteristics, and risk factors. A total of 802 (7.8%) participants
-
Genomic Deletion of PfHRP2 and PfHRP3 Antigens in Plasmodium falciparum Strains, Ethiopia, 2009 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-05-28
Tamirat Gebru Woldearegai, Tina Krüger, Sindew Mekasha Feleke, Hassen Mamo, Tesfaye Gelanew, Vanessa Krohmer, Sabine Belard, Peter G. Kremsner, Jana Held, Miriam Rodi, Andrea KreidenweissPlasmodium falciparum strains lacking P. falciparum histidine-rich protein 2 (PfHRP2) and PfHRP3 threaten malaria rapid test reliability. We show that pfhrp2/pfhrp3–deleted parasites circulated in Ethiopia as early as 2009, before widespread PfHRP2-based rapid test use, and had high pfhrp3 deletion prevalence. Monitoring of pfhrp2 and of pfhrp3 deletions is needed.
-
Pulmonary Tuberculosis Associated Chronic Pulmonary Aspergillosis: Urgent Need to Standardize Reporting of Prevalence Studies. Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-28
Felix Bongomin,David W Denning -
Low Rate of Documented Measles Immunity in a Large Urban HIV Clinic Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-28
Hayden S Andrews, Hannah L Blanchard, Shining Yang, Netanya S UtayPeople with HIV (PWH) have increased risk of complications from measles. Only 11.2% of 13,622 PWH in one U.S. clinic had presumptive measles immunity. The most significant correlates of seronegativity were younger age, white race, and CD4 count <200 cells/µL. Increasing measles immunity in PWH is essential given increasing outbreaks.
-
Single-cell targeted transcriptomics reveals subset-specific immune signatures differentiating asymptomatic and cardiac patients with chronic Chagas disease J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-28
Thaiany G Souza-Silva, Amanda Figueiredo, Katia L P Morais, Juliana Apostólico, Alexandre Pantaleao, Antônio Mutarelli, Silvana Silva Araújo, Maria do Carmo Pereira Nunes, Kenneth J Gollob, Walderez O DutraBackground Human infection with Trypanosoma cruzi leads to Chagas disease that induces profound changes in the immune response across different cell subsets, influencing parasite control and disease pathology. Dissecting the functional characteristics of distinct immune cells in patients with the asymptomatic (indeterminate – IND) or with the cardiac (CCC) clinical forms is crucial for unveiling mechanisms
-
Mendelian randomisation and infection: pitfalls and promises J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-28
Fergus Hamilton, Guillaume Butler-Laporte, George Davey SmithMendelian randomisation (MR) is an increasingly common study design in infectious diseases (ID). It holds promise for identifying causes and consequences of infections where conventional epidemiology has struggled, and can highlight plausible drug targets, as predating successful COVID-19 trials (baricitinib, tocilizumab). However, many current applications provide limited insight due to violations
-
Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole and Hydroxyitraconazole in Sudanese Patients With Eumycetoma J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-28
Wan-Yu Chu, Ahmed H Fahal, Eiman Siddig Ahmed, Sahar Mubarak Bakhiet, Osama Elhadi Bakhiet, Lamis Ahmed Fahal, Abubakar Ahmed Mohamed, El Sammani Wadaa Mohamedelamin, Mustafa El Nour Bahar, Hadil Yassir Attalla, Emmanuel Edwar Siddig, Najwa A Mhmoud, Ahmed Mudawi Musa, Peelen Oyieko, Thaddaeus Egondi, Roger J Brüggemann, Katsura Hata, Nathalie Strub-Wourgaft, Fabiana Alves, Borna A Nyaoke, Eduard EBackground The first clinical trial on eumycetoma was recently conducted in Sudan, comparing oral fosravuconazole, prodrug of active ravuconazole, with the standard-of-care oral itraconazole. Building on this trial, the present study aimed to characterize the pharmacokinetics-pharmacodynamics (PK-PD) of ravuconazole, itraconazole and hydroxyitraconazole in patients with eumycetoma and guide selection
-
Prevotella intermedia Synergistically Exacerbates Pneumonia Induced by Oral Streptococci J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-27
Hiroki Ashizawa, Naoki Iwanaga, Kazuki Nemoto, Tatsuro Hirayama, Masataka Yoshida, Kazuaki Takeda, Shotaro Ide, Masato Tashiro, Naoki Hosogaya, Takahiro Takazono, Kosuke Kosai, Noriho Sakamoto, Koichi Izumikawa, Mariko Naito, Yoshimasa Tanaka, Katsunori Yanagihara, Kazuhiro Yatera, Hiroshi MukaeBackground The precise mechanisms of respiratory infection caused by oral anaerobic bacteria remain elusive. Unexpectedly, bacterial microbiota analysis using 16S rRNA revealed “hidden” mixed infections of anaerobic bacteria and commensal oral Streptococcus species in patients with community-acquired pneumonia (CAP). The study aimed to elucidate the mechanisms by which Prevotella intermedia exacerbates
-
Improving Molecular Epidemiological Surveillance of Strongyloidiasis Upon Differentiation of Strongyloides fuelleborni fuelleborni From Strongyloides stercoralis J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-27
Lucas J Cunningham, William D Nevin, Jaco J Verweij, Dora Buonfrate, Salvatore Scarso, Virak Khieu, Angus M O’Ferrall, Sarah Rollason, J Russell StothardMolecular epidemiological surveillance for zoonotic strongyloidiasis is confounded by a genus-specific TaqMan probe assay that conflates Strongyloides fuelleborni fuelleborni with Strongyloides stercoralis. To improve surveillance, we developed and validated a novel duplex species-specific TaqMan probe assay, screening a representative collection of available clinical samples. Our assay was highly
-
Estimating ZIKV seroprevalence in a DENV endemic population: the use of blood donors and multiplex serology to monitor arbovirus outbreaks in the Dutch Caribbean J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-27
Louella M R Kasbergen, Reina S Sikkema, Felicity Chandler, Janko H G van Beek, Yaskara Halabi, Norédiz Lourents, Eugene G Maduro, Izzy Gerstenbluth, Ashley Duits, Marion P G KoopmansBackground The geographic range of flaviviruses is expanding, as evidenced by the increase in dengue virus (DENV) cases and the recent emergence of Zika virus (ZIKV) in the Americas. Studying seroprevalence of flaviviruses in (hyper)endemic regions is challenging due to extensive antibody cross-reactivity. Over the past decade, Aruba and Curaçao have experienced DENV and ZIKV outbreaks, of which the
-
Herpes simplex virus (HSV) neurovirulence across the human lifespan J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-26
A Dutton, C K Hayes, D A Leib, L N AkhtarThe ability of herpes simplex virus (HSV) to establish lifelong latency in sensory neurons makes it one of the most pervasive viruses worldwide. Although most HSV infections are asymptomatic or cause limited cutaneous symptoms, some give rise to serious central nervous system (CNS) manifestations. Both primary HSV infection and subsequent reactivation events can cause viral replication and spread within
-
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY) Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-24
Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, Anna Holmes, Natalia Betancourt, Deepali Gupta, Kazima Tosh, Kristin Narayan, Ed Campanaro, Chloe Katz, Anne-Marie Phelan, Ilker Yalcin, Mark Wingertzahn, Pamela Hawn, Pete Schmidt, Yong Li, Myra PopejoyBackground We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant immunocompromise in the phase 3 CANOPY trial. Methods Eligible participants (≥18 years; negative for current SARS-CoV-2 infection) received 2 intravenous 4500-mg pemivibart infusions (cohort A) or were randomized 2:1 to receive blinded pemivibart or placebo
-
Evaluating the diagnostic utility of 16S ONT Sequencing in patients with Central Nervous System infections and its usefulness in Antimicrobial Stewardship J. Infect. Dis. (IF 5.0) Pub Date : 2025-05-24
Do Van Dong, Le Thi Kieu Linh, Nguyen Thi Tuyet Nga, Nghiem Xuan Hoan, Nguyen Thi Khanh Linh, Tran Thi Thanh Huyen, Hoang Xuan Quang, Tran Thi Lien, Van Dinh Trang, Vu Viet Sang, Peter G Kremsner, Le Huu Song, Dennis Nurjadi, Thirumalaisamy P VelavanBackground Central nervous system (CNS) infections pose a significant public health challenge in resource-limited settings. Traditional culture-based and targeted molecular diagnostic methods have limitations in sensitivity and speed. This study retrospectively analysed the data and CSF samples from our previous study to assess the diagnostic efficacy of untargeted 16S ONT sequencing compared to conventional
-
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-22
Nicholas I Paton, Christopher Cousins, Intan P Sari, Erlina Burhan, Nan-Kai Ng, Victoria B Dalay, Celina Suresh, Tutik Kusmiati, Ka Lip Chew, Vincent M Balanag, Qingshu Lu, Rovina Ruslami, Irawaty Djaharuddin, Jani J R Sugiri, Rholine S Veto, Christine Sekaggya-Wiltshire, Anchalee Avihingsanon, Jitendra Kumar Saini, Padmasayee Papineni, Andrew J Nunn, Reinout Van CrevelBackgroundWHO recommends a 2-month optimal duration for new drug regimens for rifampicin-susceptible tuberculosis. We aimed to investigate the efficacy and safety of the 8-week regimens that were assessed as part of the TRUNCATE management strategy of the TRUNCATE-TB trial. MethodsTRUNCATE-TB was a multi-arm, multi-stage, open-label, randomised controlled trial in which participants aged 18–65 years
-
COVID-19: the challenges of a digital pandemic | Risk and crisis communication during the COVID-19 pandemic: muddled messages, Martin Ndlela (Ed.), Routledge (2024), p. 200, £39·99, ISBN: 9781032513577 Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-22
Henrietta DunsmuirNo Abstract
-
Is shorter the solution for tuberculosis treatment? Lancet Infect Dis (IF 36.4) Pub Date : 2025-05-22
Rosa Herrera, Jennifer FurinNo Abstract
-
Lyme Disease Testing Practices, Wisconsin, USA, 2016–2019 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2025-05-22
Kiersten J. Kugeler, Erica Scotty, Austin Earley, Alison F. Hinckley, Sarah A. Hook, Courtney C. Nawrocki, Alexandra M. Linz, Jennifer Meece, Anna M. SchotthoeferPositive laboratory results are increasingly used for Lyme disease surveillance in the United States. We found 6%–15% of persons with a positive test each year tested positive in a prior year; repeat testing frequency increased with patient age. Repeat testing of persons with previous seropositivity could affect surveillance data interpretation.
-
Respiratory Transmission Potential of Severe Fever with Thrombocytopenia Syndrome Bunyavirus: Evidence from Intranasal Exposure in a Humanized Mouse Model Emerg. Microbes Infect. (IF 8.4) Pub Date : 2025-05-23
Dafeng Lu, Yifang Han, Ruowei Xu, Chunfang Wang, Mingke Qin, Jianwei Shi, Fuqiang Ye, Jinhai Zhang, Zhenghan Luo, Yuhe Wang, Hong Lin, Peiqi Jia, Jin Zhu, Chunhui WangSevere Fever with Thrombocytopenia Syndrome Bunyavirus (SFTSV) is a highly lethal pathogen with expanding endemic regions in Asia. While primarily transmitted by ticks, recent evidence suggests potential airborne transmission, raising significant public health concerns. This study investigates the potential for respiratory transmission and pathogenesis using humanized NCG mice inoculated with SFTSV
-
Identification of Clonorchis sinensis in Bronchoalveolar Lavage Fluid and Peripheral Blood Using Next-Generation Sequencing in a Patient with Septic Shock: a Case Report and Literature Review Emerg. Microbes Infect. (IF 8.4) Pub Date : 2025-05-23
Weipeng Liu, Mengting Su, Dongjing Zhang, Siqi Liu, Yin Zhang, Zhengfei YangSummaryWe present a case report of a 59-year-old male diagnosed with pancreatic cancer with multiple abdominal metastases, in whom metagenomic next-generation sequencing unexpectedly identified Clonorchis sinensis genomic sequences in both bronchoalveolar lavage fluid and peripheral blood specimens. Subsequent examination further confirmed the presence of viable C. sinensis eggs in the stool samples
-
Responding to additional considerations regarding the risk of acute kidney injury with cefepime versus piperacillin-tazobactam in patients with septic shock. Clin. Infect. Dis. (IF 8.2) Pub Date : 2025-05-23
Asad E Patanwala,David E Nix,Thomas E Hills,Brian L Erstad